These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 23338623

  • 21. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L.
    Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626
    [Abstract] [Full Text] [Related]

  • 22. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [Abstract] [Full Text] [Related]

  • 23. Exogenous glucagon-like peptide 1 reduces contractions in human colon circular muscle.
    Amato A, Baldassano S, Liotta R, Serio R, Mulè F.
    J Endocrinol; 2014 Apr; 221(1):29-37. PubMed ID: 24443715
    [Abstract] [Full Text] [Related]

  • 24. Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome.
    O'Malley D.
    Exp Physiol; 2019 Jan; 104(1):3-10. PubMed ID: 30444291
    [Abstract] [Full Text] [Related]

  • 25. Alternation of substance P-containing neural pathways in a rat model of irritable bowel syndrome with rectal distension.
    Wang WF, Yang YS, Peng LH, Sun G.
    Chin J Dig Dis; 2006 Jan; 7(4):211-8. PubMed ID: 17054583
    [Abstract] [Full Text] [Related]

  • 26. Increased colonic motility in a rat model of irritable bowel syndrome is associated with up-regulation of L-type calcium channels in colonic smooth muscle cells.
    Zhang M, Leung FP, Huang Y, Bian ZX.
    Neurogastroenterol Motil; 2010 May; 22(5):e162-70. PubMed ID: 20122129
    [Abstract] [Full Text] [Related]

  • 27. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome.
    Zhou TR, Huang JJ, Huang ZT, Cao HY, Tan B.
    World J Gastroenterol; 2018 Feb 14; 24(6):693-705. PubMed ID: 29456408
    [Abstract] [Full Text] [Related]

  • 28. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
    Zhang Y, Zhang J, Wang Q, Lei X, Chu Q, Xu GT, Ye W.
    Invest Ophthalmol Vis Sci; 2011 Jan 05; 52(1):278-85. PubMed ID: 20688733
    [Abstract] [Full Text] [Related]

  • 29. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M, Hongo M, Fukudo S.
    J Gastroenterol Hepatol; 2011 Apr 05; 26 Suppl 3():119-21. PubMed ID: 21443723
    [Abstract] [Full Text] [Related]

  • 30. Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon.
    Amato A, Rotondo A, Cinci L, Baldassano S, Vannucchi MG, Mulè F.
    Am J Physiol Gastrointest Liver Physiol; 2010 Nov 05; 299(5):G1038-44. PubMed ID: 20705903
    [Abstract] [Full Text] [Related]

  • 31. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Ozyazgan S, Kutluata N, Afşar S, Ozdaş SB, Akkan AG.
    Pharmacology; 2005 Jun 05; 74(3):119-26. PubMed ID: 15746570
    [Abstract] [Full Text] [Related]

  • 32. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors.
    Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, Mulè F.
    Neurogastroenterol Motil; 2010 Jun 05; 22(6):664-e203. PubMed ID: 20158614
    [Abstract] [Full Text] [Related]

  • 33. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
    Jensen EP, Poulsen SS, Kissow H, Holstein-Rathlou NH, Deacon CF, Jensen BL, Holst JJ, Sorensen CM.
    Am J Physiol Renal Physiol; 2015 Apr 15; 308(8):F867-77. PubMed ID: 25656368
    [Abstract] [Full Text] [Related]

  • 34. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S, Schimmer S, Oschmann J, Schiødt CB, Knudsen SM, Jeppesen CB, Madsen K, Lau J, Thøgersen H, Rudolph R.
    Biochemistry; 2007 May 15; 46(19):5830-40. PubMed ID: 17444618
    [Abstract] [Full Text] [Related]

  • 35. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L, Eutamene H.
    Pain; 2009 Jul 15; 144(1-2):209-17. PubMed ID: 19450926
    [Abstract] [Full Text] [Related]

  • 36. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY, Lee SK, Jo KJ, Song DY, Lim DM, Park KY, Bonewald LF, Kim BJ.
    Life Sci; 2013 Mar 21; 92(10):533-40. PubMed ID: 23357248
    [Abstract] [Full Text] [Related]

  • 37. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
    During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN.
    Nat Med; 2003 Sep 21; 9(9):1173-9. PubMed ID: 12925848
    [Abstract] [Full Text] [Related]

  • 38. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct 21; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

  • 39. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L.
    Clin Gastroenterol Hepatol; 2007 May 21; 5(5):550-5. PubMed ID: 17336590
    [Abstract] [Full Text] [Related]

  • 40. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A.
    Liver Int; 2011 Oct 21; 31(9):1285-97. PubMed ID: 21745271
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.